[en] BACKGROUND: A significant proportion of glioblastoma (GBM) patients are considered for repeat resection, but evidence regarding best management remains elusive. Our aim was to measure the degree of clinical uncertainty regarding reoperation for patients with recurrent GBM.
METHODS: We first performed a systematic review of agreement studies examining the question of repeat resection for recurrent GBM. An electronic portfolio of 37 pathologically confirmed recurrent GBM patients including pertinent magnetic resonance images and clinical information was assembled. To measure clinical uncertainty, 26 neurosurgeons from various countries, training backgrounds, and years' experience were asked to select best management (repeat surgery, other nonsurgical management, or conservative), confidence in recommended management, and whether they would include the patient in a randomized trial comparing surgery with nonsurgical options. Agreement was evaluated using κ statistics.
RESULTS: The literature review did not reveal previous agreement studies examining the question. In our study, agreement regarding best management of recurrent GBM was slight, even when management options were dichotomized (repeat surgery vs. other options; κ=0.198 [95% confidence interval: 0.133-0.276]). Country of practice, years' experience, and training background did not change results. Disagreement and clinical uncertainty were more pronounced within clinicians with (κ=0.167 [0.055-0.314]) than clinicians without neuro-oncology fellowship training (κ=0.601 [0.556-0.646]). A majority (51%) of responders were willing to include the patient in a randomized trial comparing repeat surgery with nonsurgical alternatives in 26/37 (69%) of cases.
CONCLUSION: There is sufficient uncertainty and equipoise regarding the question of reoperation for patients with recurrent glioblastoma to support the need for a randomized controlled trial.
Disciplines :
Surgery Neurology Oncology
Author, co-author :
Patel, Mukt; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Au, Karolyn; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Davis, Faith G; School of Public Health, University of Alberta
Easaw, Jacob C; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB
Mehta, Vivek; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Broad, Robert; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Chow, Michael M C; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Hockley, Aaron; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Kaderali, Zul; Section of Neurosurgery, GB1-Health Sciences Centre, Winnipeg, MB, Canada
Magro, Elsa; Neurosurgery service, CHU Cavale Blanche, INSERM UMR 1101 LaTIM, Boulevard Tanguy-Prigent Brest, France
Nataraj, Andrew; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
Scholtes, Félix ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurochirurgie
Chagnon, Miguel; Department of Mathematics and Statistics, André-Aisenstadt Pavillon (AA-5190
Gevry, Guylaine; Department of Radiology, Centre Hospitalier of University of Montreal (CHUM), Montreal, QC, Canada
Raymond, Jean; Department of Radiology, Centre Hospitalier of University of Montreal (CHUM), Montreal, QC, Canada
Darsaut, Tim E; Department of Surgery, Division of Neurosurgery, University of Alberta Hospital, Mackenzie Health Sciences Centre
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019;21:v1-v100.
Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842-1850.
Sonabend AM, Zacharia BE, Cloney MB, et al. Defining glioblastoma resectability through the wisdom of the crowd: a proof-of-principle study. Neurosurgery. 2017;80:590-601.
Helseth R, Helseth E, Johannesen TB, et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand. 2010;122:159-167.
Ryken TC, Kalkanis SN, Buatti JM, et al. The role of cytoreductive surgery in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2014;118:479-488.
Archavlis E, Tselis N, Birn G, et al. Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm. J Neurooncol. 2014;119:387-395.
Clarke JL, Ennis MM, Yung WK, et al. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol. 2011;13:1118-1124.
Michaelsen SR, Christensen IJ, Grunnet K, et al. Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution. BMC Cancer. 2013;13:402-413.
Suchorska B, Weller M, Tabatabai G, et al. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. Neuro Oncol. 2016;18:549-556.
Yong RL, Wu T, Mihatov N, et al. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma. J Neurosurg. 2014;121:802-809.
Mansouri A, Cooper B, Shin SM, et al. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered? J Neurosurg. 2016;124:558-568.
Walid MS, Robinson JS III, Robinson JS. Shortfalls in published neurosurgical literature. J Clin Neurosci. 2012;19:942-945.
Fahed R, Darsaut TE, Farzin B, et al. Measuring clinical uncertainty as a preliminary step to randomized controlled trials. J Clin Epidemiol. 2019;112:96-98.
Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141-145.
Fahed R, Darsaut TE, Farzin B, et al. Measuring clinical uncertainty and equipoise by applying the agreement study methodology to patient management decisions. BMC Med Res Methodol. 2020;20:214.
Kottner J, Audigé L, Brorson S, et al. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol. 2011;64:96-106.
Donner A, Rotondi MA. Sample size requirements for interval estimation of the kappa statistic for interobserver agreement studies with a binary outcome and multiple raters. Int J Biostat. 2010;6:31.
Cicchetti DV, Feinstein AR. High agreement but low kappa: II. resolving the paradoxes. J Clin Epidemiol. 1990;43:551-558.
Feinstein AR, Cicchetti DV. High agreement but low kappa: I. the problems of two paradoxes. J Clin Epidemiol. 1990;43: 543-549.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
Raymond J, Darsaut TE, Altman DG. Pragmatic trials used as optimal medical care: principles and methods of care trials. J Clin Epidemiol. 2014;67:1150-1156.
Robin AM, Lee I, Kalkanis SN. Reoperation for recurrent glioblastoma multiforme. Neurosurg Clin N Am. 2017;28:407-428.
Gorlia T, Stupp R, Brandes AA, et al. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. Eur J Cancer. 2012;48:1176-1184.
Schucht P. RESURGE: Surgery for recurrent Glioblastoma; 2020. Available at: https://clinicaltrials.gov/ct2/show/NCT02394626.
Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637-648.
Raymond J, Magro E, Darsaut TE. Clinical research training integrated to practice in neurosurgery and interventional neuroradiology. Neuro-Chirurgie. 2018;64:391-394.
Raymond J, Darsaut TE, Roy D. Care and research concepts should be revised to practice outcome-based medical care. J Clin Epidemiol. 2019;116:155-160.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.